# Contact Legit TB-500: Corrections and Editorial Inquiries

> Contact Legit TB-500 — for corrections, citation questions, and editorial inquiries about the TB-500 research digest. We do not sell, supply, or prescribe any substance.

Corrections, citation questions, and editorial inquiries. Not a sales, clinical, or prescription channel.

## What to write to us about

This is an editorial contact channel for the TB-500 digest. The most useful messages flag a citation that should be corrected, a study we missed, or a place where the fragment-versus-full-length-protein distinction could be sharper. We read the literature for a living and we would rather fix an error than defend one, so corrections are welcome and acted on.

What this channel is not: it is not a way to buy, order, or source any substance, and it is not a clinical or prescribing service. We do not sell, supply, or recommend TB-500, and we cannot advise on personal use, dosing, or access to compounded preparations. Questions of that kind belong with an appropriately licensed prescriber, not with an editorial desk.

## Using the form

Use the form below for corrections and editorial inquiries. A short, specific note — the page, the claim, and the source you are referencing — gets the fastest and most accurate reply. We do not collect health information, and we ask that you not send any; this is a digest of published research, and the conversation we can have is about that record and its sources, nothing more. For the regulatory standing of the compound, the legal-status page is the place to start, and the references page lists every source we cite.

---

Legit TB-500 runs the thymosin beta-4 literature like a status check: the seven-mer marked present, the full-length protein where the data actually live marked separately, the human-evidence column returning zero, and FDA's standing quoted straight — a console for verifying claims, not a clinic, a pharmacy, or a place anything is sold.